Literature DB >> 3812527

Steroid-induced Kaposi's sarcoma in a patient with pre-AIDS.

E P Schulhafer, M E Grossman, G Fagin, K E Bell.   

Abstract

Kaposi's sarcoma is known to occur in a variety of immunosuppressed patients. The course of the disease varies depending on the underlying risk factors. A male homosexual patient in whom Kaposi's sarcoma developed while he was being treated with prednisone for Henoch-Schönlein purpura is described. The resolution of his lesions once the steroid was discontinued places him in the group of patients whose main risk factor is the steroid itself, rather than the acquired immune deficiency syndrome (AIDS) risk group. A review of the literature on steroid-treated patients in whom Kaposi's sarcoma developed is presented.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3812527     DOI: 10.1016/0002-9343(87)90076-3

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  13 in total

1.  Retinoid antagonism of NF-IL6: insight into the mechanism of antiproliferative effects of retinoids in Kaposi's sarcoma.

Authors:  S Nagpal; J Cai; T Zheng; S Patel; R Masood; G Y Lin; S Friant; A Johnson; D L Smith; R A Chandraratna; P S Gill
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

2.  Kaposi's sarcoma in a patient with rheumatoid arthritis and polymyositis treated with corticosteroids.

Authors:  S R Weiner; D T Noritake; H E Paulus
Journal:  West J Med       Date:  1988-06

3.  Double blind randomised placebo controlled trial of adjunctive prednisolone in the treatment of effusive tuberculous pericarditis in HIV seropositive patients.

Authors:  J G Hakim; I Ternouth; E Mushangi; S Siziya; V Robertson; A Malin
Journal:  Heart       Date:  2000-08       Impact factor: 5.994

4.  Kaposi's sarcoma of the colon in a young HIV-negative woman with Crohn's disease.

Authors:  T Puy-Montbrun; F Pigot; P N Vuong; R Ganansia; J Denis
Journal:  Dig Dis Sci       Date:  1991-04       Impact factor: 3.199

5.  Expression and cytokine regulation of glucocorticoid receptors in Kaposi's sarcoma.

Authors:  W X Guo; T Antakly; M Cadotte; Z Kachra; L Kunkel; R Masood; P Gill
Journal:  Am J Pathol       Date:  1996-06       Impact factor: 4.307

Review 6.  Oral combination chemotherapy in the management of AIDS-related lymphoproliferative malignancies.

Authors:  S C Remick; N Sedransk; R Haase; M Craffey; N Subramanian; A Dowlati; T Nazeer; C Ramnes; C Blanchard; D Mastrianni; L Balducci; J Horton; J C Ruckdeschel
Journal:  Drugs       Date:  1999       Impact factor: 9.546

7.  AIDS-related Kaposi's sarcoma: evidence for direct stimulatory effect of glucocorticoid on cell proliferation.

Authors:  W X Guo; T Antakly
Journal:  Am J Pathol       Date:  1995-03       Impact factor: 4.307

Review 8.  A critical analysis of the HIV-T4-cell-AIDS hypothesis.

Authors:  E Papadopulos-Eleopulos; V F Turner; J M Papadimitriou; D Causer; B Hedland-Thomas; B A Page
Journal:  Genetica       Date:  1995       Impact factor: 1.082

Review 9.  Kaposi sarcoma in anti-neutrophil cytoplasmic antibody-associated vasculitis: a case-based review.

Authors:  Benedict K Tiong; Arun S Singh; G Peter Sarantopoulos; Tanaz A Kermani
Journal:  Rheumatol Int       Date:  2021-02-23       Impact factor: 2.631

10.  Steroids are a risk factor for Kaposi's sarcoma-immune reconstitution inflammatory syndrome and mortality in HIV infection.

Authors:  Mónica Fernández-Sánchez; María C Iglesias; Yuria Ablanedo-Terrazas; Christopher E Ormsby; Claudia Alvarado-de la Barrera; Gustavo Reyes-Terán
Journal:  AIDS       Date:  2016-03-27       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.